Results 21 to 30 of about 692,862 (304)
Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. [PDF]
PLoS ONE, 2015 BACKGROUND:Infections are a frequent cause for prolonged hospitalization and increased mortality after stroke. Recent studies revealed a stroke-induced depression of the peripheral immune system associated with an increased susceptibility for infections.
Ilko L Maier +4 more
doaj +1 more source
Jurnal Kedokteran Diponegoro, 2017 Latar Belakang : Penurunan sensibilitas kornea merupakan salah satu efek samping dari penggunaan beta blocker topikal yang dapat menimbulkan berbagai masalah seperti penurunan reflex mengedip, penurunan kemampuan penyembuhan luka pada kornea, dan terkait
Tusita Devi, Fifin Luthfia Rahmi
doaj +1 more source
Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis
Clinical Medicine Insights: Endocrinology and Diabetes, 2022 Background: Depression is associated with lower quality of life and increased risk of mortality. The prevalence of depression in chronic dialysis patients, as well as in patients with diabetes, is more than 20%. It is debated whether use of beta-blockers
Robin Lengton +6 more
doaj +1 more source
Journal of Hepatology, 2014 might have stumbled across other rather informative (and much We read with interest the recent review on beta-blockers in cirrhosis by Ge and Runyon [1]. This topic is of great importance, as non-selective beta blockers are a pharmacological mainstay in the management of patients with cirrhosis; the amount of evidence has been increasing substantially ...
Thalheimer, Ulrich +2 more
openaire +2 more sources
Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey
ESC Heart Failure, 2021 Aims The use of beta‐blocker therapy in cardiac amyloidosis (CA) is debated. We aimed at describing patterns of beta‐blocker prescription through a nationwide survey.
Giacomo Tini +29 more
doaj +1 more source
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease [PDF]
, 2012 <p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among ...
Abergel, Helene +64 more
core +1 more source
Journal of Ophthalmology, 2017 Objective. To evaluate the efficacy and tolerability of travoprost 0.004%/timolol 0.5% fixed-dose combination (TTFC) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) inadequately controlled on beta-blocker monotherapy. Methods.
Simon Fabian Lerner +5 more
doaj +1 more source
Cardiovascular Ultrasound, 2010 Background Upright exercise stress echocardiography (SE) induces significant intraventricular gradient (IVG) and systolic anterior motion (SAM) in a large proportion of symptomatic athletes, who may therefore benefit from a negative inotropic therapy ...
Cotrim Carlos +8 more
doaj +1 more source
Pharmacology Research & Perspectives, 2023 Beta‐blocker usage is inconsistently associated with increased fall risk in the literature. However, due to age‐related changes and interindividual heterogeneity in pharmacokinetics and dynamics, it is difficult to predict which older adults are more at ...
K. J. Ploegmakers +11 more
doaj +1 more source
Medical Journal of Babylon, 2021 Background: There is controversy about the role of beta-blockers in the number of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hemin Khalid Saber
doaj +1 more source